Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
C R Bard Inc. et al v. AngioDynamics Inc.
Case Number:
1:15-cv-00218
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
June 16, 2023
AngioDynamics Wants Atty Fees From Bard In Patent Case
AngioDynamics is seeking attorney fees after a Delaware judge earlier this month invalidated C.R. Bard patents on implanted catheter receptacles that a jury had found AngioDynamics infringed.
-
June 01, 2023
Judge Wipes Out Bard's Jury Win In Medical Device IP Feud
A federal judge has determined that three C.R. Bard patents — which a jury found last year had been infringed by AngioDynamics' implantable port products — were actually invalid for multiple reasons.
-
January 31, 2023
AngioDynamics Fights For New Trial In CR Bard Patent Case
AngioDynamics says it should get a new trial after a Delaware federal jury found the company's implantable port products infringed medical device maker C.R. Bard's patents, claiming that "Bard's trial presentation was littered with improper and prejudicial arguments."
-
December 12, 2022
CR Bard, AngioDynamics Spar Over Timing Of Damages Trial
C.R. Bard and AngioDynamics have laid out different time frames on when a Delaware federal court should schedule a damages trial after a jury last month found AngioDynamics' implantable port products infringed Bard's patents.
-
November 23, 2022
Del. Jury Says AngioDynamics Infringes CR Bard Patents
A Delaware federal jury has determined that some of AngioDynamics' implantable port products infringed medical device maker C.R. Bard's patents, with the company saying in a U.S. Securities and Exchange Commission report Wednesday that it "strongly disagrees" with the verdict.
-
April 22, 2022
COVID Illness Delays Bard, AngioDynamics Patent Trial In Del.
COVID-19 will delay trial in medical device maker C.R. Bard's patent suit against AngioDynamics after a member of the defense team contracted the virus, a Delaware federal judge said Friday.
-
March 03, 2022
AngioDynamics Loses Bid To Pause Patent Row With Bard
A federal magistrate judge has refused to pause medical device maker C.R. Bard's lawsuit accusing AngioDynamics of infringing three patents, despite a pending appeal in another case Bard filed against a separate company involving separate patents.
-
April 26, 2019
Del. Judge Tosses Bard's $67.5M Vascular Port IP Case
A Delaware federal judge on Friday tossed a lawsuit by a subsidiary of medical device maker C.R. Bard Inc. accusing rival AngioDynamics Inc. of infringing three patents related to identifying vascular access ports and seeking $67.5 million, finding that the labeling of the ports is "old technology" that cannot be patented.
-
March 04, 2019
Bard Seeks $67M Damages Award In Vascular Port IP Case
A subsidiary of medical device maker C.R. Bard Inc. told a Delaware federal jury Monday that it is owed $67.5 million in damages from competitor AngioDynamics Inc. for its infringement of three patents related to fluid injection port technology.